跳至主要内容
临床试验/NCT03391427
NCT03391427已完成不适用

Ketamine, Lidocaine and Combination for Postoperative Analgesia in Open Liver Resection: A Prospective, Randomized, Four-arm, Double Blind, Placebo Controlled Trial

Lawson Health Research Institute1 个研究点 分布在 1 个国家目标入组 124 人开始时间: 2011年3月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
124
试验地点
1
主要终点
Opioid consumption

研究概览

简要总结

Lidocaine and ketamine both are being used for perioperative analgesia. Perioperative lidocaine infusion has been shown to reduce postoperative pain and opioid consumption. Perioperative low dose Ketamine has shown improved postoperative pain and reduced opioid usage. We therefore tested the hypothesis that the combination would provide better analgesia in the milieu of intrathecal morphine.

详细描述

All study participants were monitored according to American Society of Anesthesiologists guidelines. All received intrathecal morphine (300 to 400 mcg) at L3-4 interspace via 25 G Whitacre needle. Participants were then randomized (computer generated) into one of four groups.

General anesthesia was induced and endotracheal intubation was done. Immediately, after intubation, Lidocaine group (L) received a Lidocaine infusion at 0.33 mg/kg/h.

The Ketamine group (K) received a ketamine infusion at 70 mcg/Kg/h. The Lidocaine-Ketamine group (LK) received a Lidocaine infusion at 0.33 mg/kg/h plus a Ketamine infusion at 70 mcg/Kg/h.

The control group (P) received a normal saline infusion to keep the blind. The infusions were stopped approximately 30-45 minute before the completion of surgery.

All participants received a hydromorphone patient-controlled analgesia (PCA) via a pump. All were given acetaminophen 650 mg every 6 hrs for 4 days.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

盲法说明

All persons are blinded as the drug is formulated by the investigator who is not the care giver or outcomes assessor

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ASA physical status 2-4
  • Elective major liver resection
  • Signed informed consent

排除标准

  • ICU admission after surgery
  • tracheal extubation not planned after surgery
  • language barrier
  • mental impairment
  • severe coagulopathy
  • chronic pain or opioid dependance or both
  • alcohol/substance abuse
  • allergy to the study drugs
  • refusal for spinal
  • infection at site of spinal

研究组 & 干预措施

Lidocaine

Experimental

This group will receive lidocaine infusion perioperatively

干预措施: Lidocaine (Drug)

Ketamine

Experimental

This group will receive ketamine infusion perioperatively

干预措施: Ketamine (Drug)

Lidocaine+ketamine

Experimental

This group will receive a combination of lidocaine and ketamine infusion, perioperatively

干预措施: Lidocaine+ketamine (Drug)

placebo

Placebo Comparator

This group will receive saline infusion as placebo perioperatively

干预措施: Saline (Drug)

结局指标

主要结局

Opioid consumption

时间窗: 24 hr

Total milligrams of opioids consumed would be measured

次要结局

  • Chronic pain(12 weeks)
  • Patient satisfaction(72 hrs)
  • Opioid consumption(72 hrs)
  • Opioid related side effects(72 hrs)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shalini Dhir

Associate Professor

Lawson Health Research Institute

研究点 (1)

Loading locations...

相似试验

Ketamine, Lidocaine and Combination for... | 临床试验